About Heart Failure

Heart Failure is a chronic progressive disease that continues to contribute to increasing rates of mortality and morbidity. There are several recent developments in heart failure disease management, including new classes of medications and unique combination therapies.

In 2022, guidelines for heart failure management were updated to reflect these findings. Updates include new classifications of heart failure, four classes of goal-directed medication therapy, recommendations for SGLT2 inhibitors, recommendations or screening amyloid patients, an emphasis on team-based care in heart failure therapy referrals, and management recommendations for heart failure patients with other comorbid conditions such as atrial fibrillation, type 2 diabetes, hypertension, and much more.

Resources

Provider Tools

ATTR-CM Resources

November 19, 2024

Provider Tools

ATTR-CM Glossary

November 19, 2024

Courses

0.75 CE contact hours

0.75 Pharmacology contact hours

Free

1 CE contact hours

0.25 Pharmacology contact hours

Free

0.5 CE contact hours

0 Pharmacology contact hours

Free

0.85 CE contact hours

0.85 Pharmacology contact hours

Free

0.75 CE contact hours

0.25 Pharmacology contact hours

Free

Podcast Episodes

Heart Failure

Heart Failure Management: SGLT2i and GLP-1 RA Mechanism of Action

Often prescribed for obesity, SGLT2is and GLP-1 RAs have a role in…

Health Equity, Heart Failure

Heart Failure Management: Health Equity and Access to Care

Health equity issues, including access to medications, significantly impact patients with heart…

Heart Failure

Cardiovascular Nursing and Hypertrophic Cardiomyopathy: The Basics

The Basics of Hypertrophic Cardiomyopathy Hypertrophic Cardiomyopathy (HCM) is the most common…